^
    Back
    Association details:
    Biomarker:ASNS underexpression
    Cancer:Ovarian Cancer
    Drug:IPN60090 (Glutaminase inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    Source:
    Technology Networks
    Title:

    New Therapy for Lung and Ovarian Cancer Advances to Early-stage Clinical Development

    Published date:
    04/27/2020
    Excerpt:
    ...low expression of the metabolic protein asparagine synthetase (ASNS) in ovarian cancers predicts response to IPN60090 in preclinical models.